Gilead Sciences (GILD) Tops Q2 EPS by 10c, Revises FY Guidance

July 30, 2019 4:04 PM
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.82, $0.10 better than the analyst estimate of $1.72. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Earnings

Next Articles